Jennison Associates lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 9.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,952,023 shares of the company’s stock after selling 546,799 shares during the period. Jennison Associates owned about 3.07% of BioMarin Pharmaceutical worth $521,547,000 at […]
